Suppr超能文献

衰老过程中心型脂肪酸结合蛋白水平低可能保护唐氏综合征患者免受动脉粥样硬化的侵害。

Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis.

机构信息

Dipartimento di Scienze Biomediche per la Salute, Cattedra di Patologia Clinica, Università degli Studi di Milano, Via Mangiagalli 31, Milan, 20133, Italy.

出版信息

Immun Ageing. 2013 Jan 22;10(1):2. doi: 10.1186/1742-4933-10-2.

Abstract

BACKGROUND

Aging is considered an important independent risk factor for atherosclerosis. Down syndrome people (DS) display an accelerated aging process compared to healthy subjects, anyway they are relatively resistant to developing atherosclerosis. The mechanisms involved in such protective effect are not well known. Since heart-type fatty acid binding protein (H-FABP) is a protein involved in the transport of fatty acids and it has been recently correlated with the presence of atherosclerosis, we aimed to measure H-FABP level both in DS and in healthy subjects during aging to evaluate the association between this molecule, aging and atherosclerosis.

FINDINGS

We quantified plasmatic H-FABP level in three groups of male DS and age-matched healthy subjects (children, age 2-14 years; adults, age 20-50 years; elderly, > 60 years) using a biochip array analyzer. We observed that aging is associated with increased H-FABP level in healthy subjects but not in DS which display both the same protein level in the different ages of life and have also lower level compared to their age-matched healthy subjects.

CONCLUSION

Reduced H-FABP level during aging in DS may play a protective role against atherosclerosis. The potential involvement of H-FABP in the relationship between aging, atherosclerosis and development of coronary artery disease needs further investigations.

摘要

背景

衰老被认为是动脉粥样硬化的一个重要独立危险因素。唐氏综合征患者(DS)与健康受试者相比,表现出加速的衰老过程,但他们相对不易发生动脉粥样硬化。这种保护作用的机制尚不清楚。由于心脏型脂肪酸结合蛋白(H-FABP)是一种参与脂肪酸转运的蛋白质,并且最近与动脉粥样硬化的存在相关,因此我们旨在测量 DS 和健康受试者在衰老过程中的 H-FABP 水平,以评估该分子、衰老与动脉粥样硬化之间的关系。

结果

我们使用生物芯片阵列分析仪定量测量了三组男性 DS 和年龄匹配的健康受试者(儿童,2-14 岁;成人,20-50 岁;老年人,>60 岁)的血浆 H-FABP 水平。我们观察到,在健康受试者中,衰老与 H-FABP 水平的升高有关,但在 DS 中则没有,DS 在不同的生命阶段都表现出相同的蛋白水平,并且与年龄匹配的健康受试者相比,其水平也较低。

结论

DS 中衰老过程中 H-FABP 水平的降低可能对动脉粥样硬化起到保护作用。H-FABP 在衰老、动脉粥样硬化和冠心病发展之间的关系中的潜在作用需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d9c7/3575247/dab9942135a9/1742-4933-10-2-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验